Clinical Trials Logo

Clinical Trial Summary

Although IV salbutamol is frequently used in children in a wide range, pharmacodynamic data are scarce. To date, there is an insufficient evidence base to guide initial and subsequent dosing recommendation for its IV use in children. Especially the need for a loading dose needs to be addressed. Therefore, pharmacodynamic and kinetic data are needed to guide initial dosing strategies of IV salbutamol in children. To assess the efficacy of a loading dose of intravenous salbutamol in children admitted to a PICU for severe acute wheeze or severe acute asthma. Efficacy is measured by the reduction in asthma score (Qureshi) at 1 hour after administration of the loading dose, compared to placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03493503
Study type Interventional
Source Erasmus Medical Center
Contact
Status Completed
Phase Phase 4
Start date April 5, 2017
Completion date May 21, 2019

See also
  Status Clinical Trial Phase
Completed NCT02936778 - Status Asthmaticus on the Intensive Care Prospective - STATIC PRO